Washington State University researcher Santanu Bose has been awarded a $3.04M grant from the National Institutes of Health for research that could lead to new treatment options for human respiratory syncytial virus, commonly known as RSV, and other respiratory viral infections.
The five-year grant will support a project aimed at understanding how the body’s own immune response to RSV can cause significant lung damage leading to inflammatory diseases like pneumonia and how that process may be blocked by therapeutic agents to combat lung disease.